Tianjin Tianyao Pharmaceuticals (600488) Stock Overview

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It also exports its products to the United States, Southeast Asia, Europe, South America, Africa, and internationally. The company was founded in 1999 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd.